AREVA ( back to the Home Page )

Log in
This page allows you to manage all your electronic subscriptions on this site.
Register
Suscribe to the AREVA dashboard give you an access to newsletters, news, and email alerts from the Dialogue section...

AREVA Foundation supports malaria research program

mosquito vector of the malaria

As a natural extension of the group’s health policy, AREVA Foundation has chosen to support malaria research conducted by Institut Pasteur through CERMES, the medical and health research center in Niamey, Niger.

A research program consisting of two interrelated parts:

1. Improved biological diagnosis of malaria. The purpose of this project is to design, produce and validate a fast, reliable, inexpensive diagnostics test. A standard strip-type test will be created based on reagents. The strips, to be produced locally, should be at least as reliable as commercial tests and will cost less (0.15 euros per unit).

The expected benefits are the creation of local know-how, strengthened testing capabilities in Niger, cost reduction of treatment, and the establishment of a base of diagnostic tools for other pathologies. Some 5,000 people with suspected cases of malaria will be tested in the health centers.

2. Monitoring of treatment effectiveness and in particular resistance to antimalarial drugs by instituting intervention protocols suited to the epidemics encountered in Niger. These will:

  • establish rules for patient management while avoiding the spread of new resistance;
  • map resistance to treatment in different regions of the country;
  • determine the type and frequency of mutations associated with resistance to antimalarial drugs.

Malaria, the world’s most prevalent parasitic infection

Some 40% of the world’s population is exposed to malaria, particularly in sub-Saharan Africa, where it is the leading cause of death. Malaria is currently responsible for 300 million acute cases of disease each year and at least 1 million deaths.

Malaria is thus a priority among the world's major pandemics, along with AIDS and tuberculosis. In fact, the fight against malaria is one of the United Nations’ Millennium Development Goals.